Injection series vs surgical neurectomy — ultrasound sizing, sclerosing therapy, and outcome prediction for interdigital neuroma
Interdigital (Morton's) neuroma is a compressive/fibrotic neuropathy of a common plantar digital nerve, overwhelmingly favoring the third intermetatarsal space where the medial and lateral plantar nerves converge to form a thicker, less mobile nerve trunk vulnerable to entrapment beneath the deep transverse intermetatarsal ligament. Diagnosis begins clinically but ultrasound sizing has become central to modern treatment planning, since neuroma diameter is one of the strongest predictors of response to non-surgical therapy.
History and symptoms: • Burning, sharp, or electric plantar forefoot pain, classically radiating into the adjacent two toes • Sensation of "walking on a marble" or a bunched-up sock beneath the metatarsal heads • Worsened by tight/narrow/high-heeled shoes, relieved by shoe removal and forefoot massage • Numbness or paresthesia in the involved toe borders in more advanced cases
Physical examination: • Web space palpation: focal tenderness dorsally and plantarly at the affected interspace • Mulder's click (Mulder's sign): simultaneous mediolateral compression of the metatarsal heads while squeezing the webspace dorsoplantarly produces a palpable, sometimes audible, click as the neuroma subluxes between the metatarsal heads — a hallmark though not universally present finding • Digital sensation testing for baseline documentation of any pre-existing sensory deficit
Imaging: • Ultrasound (high-frequency linear transducer, 12-18MHz): first-line imaging, dynamic, low-cost, allows real-time correlation with the point of maximal tenderness and Mulder's click; measures the hypoechoic ovoid mass and its craniocaudal/transverse diameter • MRI: reserved for atypical presentations, ambiguous ultrasound, or preoperative planning in complex/revision cases; T1 hypointense, variable T2 signal lesion in the expected webspace location • Neuroma size correlates with symptom severity and is now widely used as a decision threshold: neuromas <5mm respond favorably to conservative and injection therapy in most series, while neuromas ≥5-6mm show progressively lower response rates to non-surgical treatment and are more often ultimately treated surgically
Every patient, regardless of eventual treatment path, begins with mechanical offloading measures aimed at widening the intermetatarsal space and reducing repetitive nerve compression during gait.
Metatarsal pad/offloading orthosis: a pad or built-in orthotic dome placed just proximal to the metatarsal heads elevates and spreads the transverse metatarsal arch, reducing dynamic compression of the interdigital nerve during the propulsive phase of gait — considered the single most impactful conservative intervention.
Footwear modification: transition away from narrow toe-box, high-heeled, or tightly laced shoes; a wider forefoot box and heel height under approximately 2 inches reduces forefoot loading and lateral compression.
Activity modification: temporary reduction of high-impact activities (running, court sports) that repetitively load the forefoot.
NSAIDs: useful for symptomatic flares but do not address the underlying compressive pathology.
Manual therapy/taping: some practitioners employ webspace spreading taping techniques or manual mobilization with variable evidence.
Expected course: conservative measures alone produce durable symptom resolution in an estimated 20-50% of patients, with better response in smaller neuromas and shorter symptom duration; failure after a reasonable trial (typically 6-12 weeks) is the threshold to proceed to injection-based therapy.
Corticosteroid injection is the most widely used procedural intervention for neuroma refractory to shoe/orthotic modification, providing anti-inflammatory and analgesic effect around the fibrotic nerve segment, though benefit is often incomplete or temporary and repeated use carries a specific, well-documented risk.
Technique: • Approach: dorsal (between metatarsal heads, more common, avoids plantar fat pad puncture) or plantar • Agent: typically a mixture of a corticosteroid (methylprednisolone acetate or triamcinolone) with a local anesthetic (lidocaine or bupivacaine) for immediate diagnostic confirmation of pain relief • Ultrasound guidance is increasingly preferred over landmark-guided (blind) injection, improving accuracy of perineural placement and reducing inadvertent intraosseous or plantar fat pad injection • Series typically limited to 1-3 injections spaced approximately 3-4 weeks apart
Evidence and outcomes: • Multiple case series and comparative studies report symptomatic improvement in roughly 50-80% of patients in the short term (weeks to a few months) • Effect is frequently temporary; a meaningful proportion of initial responders relapse within 6-12 months • Response is generally better in smaller neuromas and patients with shorter symptom duration
Risks specific to corticosteroid injection: • Plantar fat pad atrophy: repeated or superficial corticosteroid injection can thin the protective plantar fat pad beneath the metatarsal heads, which paradoxically increases forefoot pain and pressure symptoms independent of the neuroma itself — this is a major reason injection number is limited and technique (avoiding overly superficial/plantar deposition) is emphasized • Skin depigmentation or subcutaneous atrophy at the injection site • Transient increase in blood glucose in diabetic patients
For neuromas that do not respond adequately to corticosteroid injection — or as a primary injection strategy in some practices — a graduated series of dilute alcohol injections induces chemical neurolysis (perineural fibrosis and axonal degeneration) of the affected nerve segment, offering an alternative to surgery with a favorable published outcome profile.
Mechanism: dilute alcohol is directly neurotoxic to peripheral nerve fibers, inducing progressive perineural fibrosis and axonal degeneration with repeated exposure — functionally a graded, staged chemical neurolysis rather than the single-session cauterization used in nail matrixectomy.
Protocol: • Concentration varies by published protocol: lower concentration (4%) with more injections, or higher concentration (20% dehydrated alcohol) with fewer sessions • Injected via dorsal webspace approach, typically ultrasound-guided, mixed with local anesthetic • Series of 4-7 injections spaced approximately 1-2 weeks apart, with symptom reassessment between sessions to determine whether to continue, escalate concentration, or proceed to surgery
Outcome evidence: • Dockery (1999) and subsequent Mozena-affiliated series report roughly 75-89% good-to-excellent symptomatic outcomes with alcohol sclerosing injection series, an outcome range that compares favorably to reported surgical neurectomy success rates while avoiding permanent numbness • Response is again size-dependent: smaller, earlier-stage neuromas respond more reliably; neuromas at the larger end of the spectrum (approaching or exceeding 6-7mm) show diminishing returns from sclerosing therapy and are more often ultimately referred for surgery • A meaningful minority of patients experience only partial or temporary relief and proceed to surgical neurectomy after a completed sclerosing series
Ultrasound-measured neuroma size functions as the single most useful quantitative decision point in the conservative-to-surgical algorithm: neuromas under approximately 5mm respond well to injection-based therapy (corticosteroid or alcohol sclerosing) in the majority of cases, while neuromas at or above 6-7mm have progressively lower injection response rates and are the group in which upfront surgical planning is most reasonably discussed with the patient.
When conservative and injection-based measures fail, or in large/longstanding neuromas with a low expected response to injection therapy, surgery is offered. The dominant surgical philosophies — excisional neurectomy versus motion/sensation-preserving decompression — trade reliability of relief against the certainty of permanent sensory change.
Dorsal neurectomy (most common approach): • Longitudinal dorsal incision over the affected webspace, deep transverse intermetatarsal ligament identified and released for exposure, the involved common digital nerve is identified proximally, traced distally past its bifurcation into the two proper digital nerves, and excised along with the neuroma segment • Nerve stump is allowed to retract proximally into the intermetatarsal space, away from the weight-bearing plantar surface, to reduce risk of a painful stump/amputation neuroma forming under load • Reliable relief of the classic burning/electric neuroma pain; expected trade-off is permanent numbness in the adjacent borders of the two involved toes, which most patients tolerate well once counseled preoperatively
Plantar approach neurectomy: • Direct plantar incision provides excellent nerve visualization and is favored by some surgeons for revision cases, but carries risk of a painful plantar scar under weight-bearing load, generally reserved for select cases
Nerve decompression (deep transverse intermetatarsal ligament release without excision): • Releases the ligament compressing the nerve without removing the nerve itself, preserving sensation • Avoids permanent numbness and stump neuroma risk entirely, but historical series report less consistent and sometimes lower-magnitude symptom relief compared with neurectomy, particularly for larger or longstanding neuromas — best considered for smaller neuromas or patients prioritizing sensation preservation over maximal reliability
Newer non-excisional options: • Cryoablation and radiofrequency ablation: percutaneous, image-guided thermal/cold ablation of the nerve, marketed as motion- and sensation-partially-preserving alternatives with shorter recovery; growing but still comparatively limited long-term outcome data relative to open neurectomy
Comparative outcomes by size: • Series stratifying by ultrasound-measured neuroma size consistently show that larger neuromas (>6-7mm) achieve more predictable and satisfactory relief with excisional neurectomy than with decompression or continued injection therapy • Overall neurectomy series report 80-85% good-to-excellent patient satisfaction, with the most common cause of dissatisfaction being either residual pain (incomplete excision, missed second neuroma) or a symptomatic stump neuroma, reported across the literature in a wide 5-30% range depending on technique (proximal retraction, burying the stump in muscle) and follow-up duration